However, it is also noteworthy that in patients with CKD stages 2–4, a well-known group of patients of a relatively high CVD risk [27], the weighted mean increase in FGF23 by native vitamin D supplementation was rather small (+5 pg/ml). Here, FGF23 is linked to chronic kidney disease.